Structural & Congenital Heart Disease

Children and young adults who were born with congenital heart disease (CHD) have an eight-fold risk of intracerebral hemorrhage (ICH) when compared to the general population, according to a Swedish study published online April 6 in Stroke. However, the absolute risk of hemorrhagic stroke remained low for both groups.
A country-wide examination of data in France showed a marked increase in transcatheter aortic valve replacement (TAVR) procedures, in addition to reduction in in-hospital mortality for all AVR subsets.
About 3 percent of patients undergoing transcatheter aortic valve replacement (TAVR) also have severe mitral stenosis and are at a greater risk of long-term adverse events, researchers reported in JACC: Cardiovascular Interventions.
Transcatheter aortic valve replacement (TAVR) was associated with lower in-hospital mortality and significantly fewer respiratory complications than surgery for patients with chronic obstructive pulmonary disease (COPD), according to study published April 1 in the Journal of the American Heart Association.
Already approved for the purpose its name implies, the Gore Cardioform septal occluder has also received the FDA’s OK for patent foramen ovale (PFO) closure to prevent recurrent ischemic stroke.
Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.
Women whose babies are born with congenital heart defects may have a higher risk of cardiovascular disease themselves, according to a study of more than one million women published online April 2 in Circulation.
Sutureless valves have recently been developed to streamline surgical aortic valve replacement (SAVR) procedures, with the hope that shorter operations lead to better outcomes. But a new study in the Journal of the American College of Cardiology suggests quicker is not always better.
Bioprosthetic heart valves used in surgical aortic valve replacement (SAVR) procedures in the early 2000s demonstrated “satisfactory” durability, according to a single-center study published in the Journal of the American College of Cardiology.
A high dose of oral ibuprofen appeared to be the best option for closing patent ductus arteriosus (PDA) in a meta-analysis of 4,802 preterm infants, researchers reported in JAMA.
Mar 23, 2018 | Healthcare Economics
Medicare was the primary payer for 90 percent of transcatheter aortic valve replacement (TAVR) hospitalizations over a recent three-year period, according to a March 19 report in JACC: Cardiovascular Interventions. With that in mind, the recent proposal to cut $473 billion from the CMS budget over the next decade could limit access to the increasingly popular procedure, researchers noted.
Occluder devices to combat congenital structural heart defects designed by the indigenous Aymara women suggest “excellent” clinical outcomes and have been approved by regulatory agencies in Canada, South America and the European Union.
Avid Star Wars fan Austin Eggleston, a 15-year-old heart transplant hopeful, finally received the news he was going to receive a new heart from Chewbacca, the big, furry character from a galaxy far, far away. 
The FDA has approved the smallest mechanical heart valve yet, Abbott’s 15-millimeter Masters HP valve, which can be used to treat babies and toddlers in need of mitral or aortic valve replacement.
A small but growing number of survivorship clinics for congenital heart disease (CHD) patients are popping up in healthcare systems across the country, but some cardiologists wonder if the model is sustainable.
Children and young adults who were born with congenital heart disease (CHD) have an eight-fold risk of intracerebral hemorrhage (ICH) when compared to the general population, according to a Swedish study published online April 6 in Stroke. However, the absolute risk of hemorrhagic stroke remained low for both groups.
A country-wide examination of data in France showed a marked increase in transcatheter aortic valve replacement (TAVR) procedures, in addition to reduction in in-hospital mortality for all AVR subsets.
About 3 percent of patients undergoing transcatheter aortic valve replacement (TAVR) also have severe mitral stenosis and are at a greater risk of long-term adverse events, researchers reported in JACC: Cardiovascular Interventions.
Transcatheter aortic valve replacement (TAVR) was associated with lower in-hospital mortality and significantly fewer respiratory complications than surgery for patients with chronic obstructive pulmonary disease (COPD), according to study published April 1 in the Journal of the American Heart Association.
Already approved for the purpose its name implies, the Gore Cardioform septal occluder has also received the FDA’s OK for patent foramen ovale (PFO) closure to prevent recurrent ischemic stroke.
Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.